Search

Author/Creator Kobalava, Zhanna D.

1. A phase‐1, open‐label, single‐dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairment. (14th September 2015)

Authors:
Csonka, Denes; Hazell, Katharine; Waldron, Edward; Lorenzo, Sebastien; Duval, Vincent; Trandafir, Lucia; Kobalava, Zhanna D.
Journal:
Journal of clinical pharmacology
Issue:
Volume 56:Number 3(2016)
Page Start:
316
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment. (27th August 2017)

Authors:
Kropeit, Dirk; McCormick, David; Erb‐Zohar, Katharina; Moiseev, Valentin S.; Kobalava, Zhanna D.; Stobernack, Hans‐Peter; Zimmermann, Holger; Rübsamen‐Schaeff, Helga
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 12(2017)
Page Start:
2678
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗